DescriptionProject ECHO® is a lifelong learning and guided practice model that revolutionizes medical education to provide best-practice specialty care and reduce health disparities. ECHO is led by an expert team that uses multi-point videoconferencing to conduct virtual learning sessions comprised of a short didactic followed by case presentations provided by participants.
New to the ECHO model? Click here to find out how Project ECHO® is changing the world.
Substance use disorders in pregnancy are a major national public health concern. The rates of Opioid Use Disorders (OUDs) are rising significantly and disproportionately in rural, southern women. Major medical associations recommend comprehensive substance use treatment for pregnant women with Perinatal Substance Use Disorders (PSUDs), including integrated delivery of obstetrical care, substance use care, medication treatment, behavioral health services, and coordinated care with linkages to community services.
The goal of this ECHO is to address the ever growing need for dissemination of evidence-based perinatal substance use comprehensive care and create a learning platform to increase inter-agency collaboration to best deliver this care and maximize patient access. The content of these ECHOs have been identified as key learning objectives by the target community of Western North Carolina serving this population.
This program was designed to satisfy, in part, the North Carolina Medical Board's CME requirement for controlled substance prescribers.
Per NCAC rules: As of July 1, 2017 all physicians (other than residents), physician assistants, nurse practitioners, podiatrists, and dentists who prescribe controlled substances must satisfy the controlled-substance prescribing CE requirements as set forth by their licensing boards. Requirements vary by discipline and board.
MAHEC engages in evaluation activities to better understand the impact of our programs. By registering for this course, you agree that we may use your personal information in evaluative research regarding this program. Any reports published will be de-identified and reported in aggregate format.
Modules (Wednesdays 12:15 - 1:15 PM)This video teleconferencing series, guided by experts, takes place over four bi-weekly modules (1-hour each) during February and April of 2020.
DATES: February 5 & 19 | April 1 & 15
|How to Dose Buprenorphine|
|Screening Inpatient vs Outpatient: How NOT to Screen Pregnant Women for Substance Use Disorders|
|Pregnancy, Buprenorphine, and Benzodiazepines Prescriptions: Let’s Talk Tapering|
|When Buprenorphine Does Not Work: When Do You Recommend Evaluation for Methadone?|
Provided by UNC Health Sciences at MAHEC and Project CARA at MAHEC, in collaboration with UNC-Horizons:
Co-sponsored by UNC Eshelman School of Pharmacy
Primary Care Physicians, NPs, PAs and their invited Behavioral Health Professionals.
- Identify and demonstrate understanding of current evidence based practice recommendations for perinatal substance use disorder and medication assisted treatment
- Demonstrate increased understanding and application of screening processes for perinatal substance use disorder
- Define screening, assessment, and treatment options for women in with opioid use disorder on buprenorphine who are also using benzodiazepines
- Elisabeth A. Johnson, PhD, FNP-BC
- Nathan Mullins, MD
- Melinda Ramage, MSN, FNP-BC, CARN-AP